Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor <scp>PTC</scp>‐209 in acute myeloid leukemia: Implications for leukemia therapy

Yuki Nishida, Kensuke Kojima|Cancer Science|2015

Cited by 27